FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4327573675> ?p ?o ?g. }

• W4327573675 endingPage "257" @default.
• W4327573675 startingPage "249" @default.
• W4327573675 abstract "Abstract Context Although the physiological effects and the performance of athletes after utilizing whole-body cryotherapy (WBC) have been widely studied, there is a lack of data on its adverse effects. It is important to be aware of the adverse effects of any treatment for its use to be properly recommended. Objectives This study aims to provide insight to any adverse effects that collegiate athletes experienced after utilizing WBC to better utilize this therapeutic modality. Methods After the Institutional Review Board (IRB) deemed exemption, all 457 Division 1-A varsity athletes were recruited via email to participate in a retrospective survey. Participants consented to the study by continuing to the questions. The inclusion criteria were that they must be 18 years of age or older, had completed WBC at that university, and were a student-athlete. The survey was six questions long, and if any of the inclusion criteria was not met, they were redirected to end the survey. The data were analyzed utilizing odds ratios. Results Of the 457 student-athletes, 11.2% (n=51) responded and 6.3% (n=29) met the inclusion criteria. Responses were obtained from women’s lacrosse (27.6%; n=8), women’s gymnastics (24.1%, n=7), field hockey (17.2%, n=5), wrestling (6.9%, n=2), football (6.9%, n=2), women’s cross country (3.5%, n=1), men’s basketball (3.5%, n=1), women’s volleyball (3.5%, n=1), softball (3.5%, n=1), and baseball (3.5%, n=1). Among the responses, 79.3% (n=23) were females and 29.7% (n=6) were males. Within 1 h of WBC, the most frequently reported adverse effects were skin rash (27.6%, n=8), itching (13.8%, n=4), and fatigue (6.9%, n=2). More than 1 h after WBC, the most frequently reported adverse effects were skin rash (20.7%, n=6), itching (10.3%, n=3), and increased energy (6.9%, n=2). When stratified by female and male athletes, for both within 1 h and more than 1 h after WBC, there were increased odds for females reporting adverse effects; however, neither were statistically significant (OR 4.58, p=0.19, 95% CI 0.46 to 45.61) (OR 3.84, p=0.25, 95% CI 0.39 to 38.36). Within 1 h of WBC, 58.6% (n=17) of subjects reported no adverse effects, and more than 1 h after WBC, 65.5% (n=19) subjects reported no adverse effects. The mean satisfaction level rating was 6.34 (range 0–10, n=29). When asked if they would do WBC again, 65.5% (n=19) responded “yes” and 34.5% (n=10) responded “no.” Conclusions In this collegiate athlete population, negative adverse effects of WBC commonly included skin burns and itching while potentially proving a beneficial adverse effect of increased energy. Subjects commonly reported no adverse effects after WBC treatment as well." @default.
• W4327573675 created "2023-03-17" @default.
• W4327573675 creator A5022113731 @default.
• W4327573675 creator A5022739667 @default.
• W4327573675 creator A5031682577 @default.
• W4327573675 creator A5040424611 @default.
• W4327573675 creator A5060801368 @default.
• W4327573675 date "2023-03-17" @default.
• W4327573675 modified "2023-10-14" @default.
• W4327573675 title "Retrospective analysis of whole-body cryotherapy adverse effects in Division I collegiate athletes" @default.
• W4327573675 cites W1483147947 @default.
• W4327573675 cites W1838871716 @default.
• W4327573675 cites W2067824905 @default.
• W4327573675 cites W2077764589 @default.
• W4327573675 cites W2107269059 @default.
• W4327573675 cites W2141614836 @default.
• W4327573675 cites W2143901326 @default.
• W4327573675 cites W2154904357 @default.
• W4327573675 cites W2179550542 @default.
• W4327573675 cites W2299312426 @default.
• W4327573675 cites W2504432904 @default.
• W4327573675 cites W2580300289 @default.
• W4327573675 cites W2611551815 @default.
• W4327573675 cites W2763233332 @default.
• W4327573675 cites W2767733153 @default.
• W4327573675 cites W2769690924 @default.
• W4327573675 cites W2794862491 @default.
• W4327573675 cites W2800073039 @default.
• W4327573675 cites W2888634970 @default.
• W4327573675 cites W2902476552 @default.
• W4327573675 cites W2971913827 @default.
• W4327573675 cites W2972552770 @default.
• W4327573675 cites W3031390020 @default.
• W4327573675 cites W3089692365 @default.
• W4327573675 cites W3138673636 @default.
• W4327573675 cites W3151264228 @default.
• W4327573675 cites W3216682199 @default.
• W4327573675 cites W4297973514 @default.
• W4327573675 cites W4365787135 @default.
• W4327573675 doi "https://doi.org/10.1515/jom-2022-0156" @default.
• W4327573675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36927611" @default.
• W4327573675 hasPublicationYear "2023" @default.
• W4327573675 type Work @default.
• W4327573675 citedByCount "0" @default.
• W4327573675 crossrefType "journal-article" @default.
• W4327573675 hasAuthorship W4327573675A5022113731 @default.
• W4327573675 hasAuthorship W4327573675A5022739667 @default.
• W4327573675 hasAuthorship W4327573675A5031682577 @default.
• W4327573675 hasAuthorship W4327573675A5040424611 @default.
• W4327573675 hasAuthorship W4327573675A5060801368 @default.
• W4327573675 hasBestOaLocation W43275736751 @default.
• W4327573675 hasConcept C103189561 @default.
• W4327573675 hasConcept C126322002 @default.
• W4327573675 hasConcept C141071460 @default.
• W4327573675 hasConcept C151730666 @default.
• W4327573675 hasConcept C166957645 @default.
• W4327573675 hasConcept C17744445 @default.
• W4327573675 hasConcept C1862650 @default.
• W4327573675 hasConcept C197934379 @default.
• W4327573675 hasConcept C199539241 @default.
• W4327573675 hasConcept C2778444522 @default.
• W4327573675 hasConcept C2779343474 @default.
• W4327573675 hasConcept C2780149145 @default.
• W4327573675 hasConcept C2781054738 @default.
• W4327573675 hasConcept C2991658862 @default.
• W4327573675 hasConcept C512399662 @default.
• W4327573675 hasConcept C71924100 @default.
• W4327573675 hasConcept C86803240 @default.
• W4327573675 hasConcept C95457728 @default.
• W4327573675 hasConceptScore W4327573675C103189561 @default.
• W4327573675 hasConceptScore W4327573675C126322002 @default.
• W4327573675 hasConceptScore W4327573675C141071460 @default.
• W4327573675 hasConceptScore W4327573675C151730666 @default.
• W4327573675 hasConceptScore W4327573675C166957645 @default.
• W4327573675 hasConceptScore W4327573675C17744445 @default.
• W4327573675 hasConceptScore W4327573675C1862650 @default.
• W4327573675 hasConceptScore W4327573675C197934379 @default.
• W4327573675 hasConceptScore W4327573675C199539241 @default.
• W4327573675 hasConceptScore W4327573675C2778444522 @default.
• W4327573675 hasConceptScore W4327573675C2779343474 @default.
• W4327573675 hasConceptScore W4327573675C2780149145 @default.
• W4327573675 hasConceptScore W4327573675C2781054738 @default.
• W4327573675 hasConceptScore W4327573675C2991658862 @default.
• W4327573675 hasConceptScore W4327573675C512399662 @default.
• W4327573675 hasConceptScore W4327573675C71924100 @default.
• W4327573675 hasConceptScore W4327573675C86803240 @default.
• W4327573675 hasConceptScore W4327573675C95457728 @default.
• W4327573675 hasIssue "5" @default.
• W4327573675 hasLocation W43275736751 @default.
• W4327573675 hasLocation W43275736752 @default.
• W4327573675 hasOpenAccess W4327573675 @default.
• W4327573675 hasPrimaryLocation W43275736751 @default.
• W4327573675 hasRelatedWork W2089799952 @default.
• W4327573675 hasRelatedWork W2115060218 @default.
• W4327573675 hasRelatedWork W2350775915 @default.
• W4327573675 hasRelatedWork W2357151527 @default.
• W4327573675 hasRelatedWork W2362227174 @default.
• W4327573675 hasRelatedWork W2369236739 @default.

• next